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CAPSULE  
 
Background: Mechanisms underlying 
carbon catabolite repression (CCR) control 
of the anaerobic degradation of aromatic 
compounds have previously remained 
elusive. 
Results: Phosphorylated AccR was 
identified as a transcriptional repressor of 
aromatics degradation operons expressed 
under anaerobic conditions.  
Conclusion: The response regulator AccR 
controls the succinate-dependent CCR in 
Azoarcus sp. CIB.  
Significance: AccR is a master regulator 
that controls anaerobic CCR in bacteria.  
 
ABSTRACT 
 Here we characterized the first 
known transcriptional regulator that 
accounts for carbon catabolite repression 
(CCR) control of the anaerobic 
catabolism of aromatic compounds in 
bacteria. The AccR response regulator of 
Azoarcus sp. CIB controls succinate-
responsive CCR of the central pathways 
for the anaerobic catabolism of 
aromatics by this strain. Phosphorylation 
of AccR to AccR-P triggers a monomer-
to-dimer transition, as well as the ability 
to bind to the target promoter and cause 
repression both in vivo and in vitro. 
Substitution of the Asp60 phosphorylation 
residue of the N-terminal receiver motif 
of AccR, to a phosphor-mimic Glu 
residue, generates a constitutively active 
derivative that behaves as a super-
repressor of the target genes. AccR-P 
binds in vitro to a conserved inverted 
repeat (ATGCA-N6-TGCAT) present at 
two different locations within the PN 
promoter of the bzd genes for anaerobic 
benzoate degradation. Because the DNA-
binding proficient C-terminal domain of 
AccR is monomeric, we propose an 
activation mechanism in which 
phosphorylation of Asp60 of AccR 
alleviates inter-domain repression 
mediated by the N-terminal domain. The 
presence of AccR-like proteins encoded 
in the genomes of other β-proteobacteria 
of the Azoarcus/Thauera group further 
suggests that AccR constitutes a master 
regulator that controls anaerobic CCR in 
these bacteria.  
 Carbon catabolite repression 
(CCR)3 is wide spread in bacteria and 
imparts a competitive advantage and 
improved fitness by establishing priorities 
in carbon utilization. This enables bacteria 
to optimizing growth rates in natural 
environments that provide complex 
mixtures of nutrients. Regulatory 
mechanism of CCR operate through 
subverting expression of genes required for 
the uptake and/or metabolism of secondary 
(less preferred) carbon sources in the 
presence of a preferred substrate (1). Such 
secondary carbon sources include aromatic 
compounds which, after carbohydrates, are 
the most widely distributed class of organic 
compounds in nature.  
Where studied, CCR mechanisms 
impact expression of pathways for the 
degradation of aromatic compounds. In 
contrast to enterics such as Escherichia 
coli, which utilize glucose as the preferred 
carbon source, soil bacteria e.g. 
Pseudomonas metabolize many organic 
acids or amino acids in preference to sugars 
(2). However, not all organic acids mediate 
CCR, nor do all organic acids provoke the 
same effect in different microorganisms 
(3,4).  
The regulatory elements involved in 
CCR of aerobic catabolism of aromatic 
compounds in different bacteria are diverse 
(2,4-8). In E. coli the cAMP-responsive 
CRP transcriptional regulator imparts CCR 
control over catabolism of aromatic 
compounds (8). In Pseudomonas strains, 
the Crc protein exerts CCR on the 
assimilation of certain aromatic compounds 
(9-11) as well as some sugars and amino 
acids (12-14). In contrast to CRP, Crc acts 
post-transcriptionally (3,4,15). Other 
proteins described to be involved in CCR 
control of aerobic catabolism of aromatics 
in Pseudomonas include PtsN and PtsO 
(nitrogen phosphotransferase system) (6,16) 
and the redox-responsive o-type terminal 
oxidase CyoB (17,18), while in Acidovorax 
sp. KKS102, CCR of biphenyl degradation 
in response to some organic acids is 
mediated by the response regulator BphQ 
(7).  
Far less is known about CCR 
control of anaerobic catabolism of aromatic 
compounds, although cases of this 
phenomenon have been reported. For 
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example, some organic acids cause CCR of 
genes involved in the anaerobic degradation 
of aromatic compounds in Thauera 
aromatica (19) and Azoarcus sp. CIB (20), 
while in closely related strains such as 
Aromatoleum aromaticum EbN1, aromatic 
compounds are preferred carbon source 
over aliphatic organic acids (21). However, 
the mechanism(s) underlying CCR in these 
cases are still unknown.  
Elucidating the molecular 
mechanism(s) underlying CCR is important 
for both basis understanding of how 
metabolism is regulated in the environment 
and for potential biotechnological 
applications such as optimizing 
bioremediation strategies and the design of 
tailor-made biocatalysts/biosensors (4). 
This is particullaly relevant for aromatic 
compounds that are difficult to degrade and 
tend to accumulate in the environment 
under both aerobic and anaerobic 
conditions. In this work we sought to use 
the denitrifying β-proteobacterium 
Azoarcus sp. CIB to analyse the 
mechanism(s) underlying CCR of anaerobic 
pathways for the dissimilation of aromatic 
compounds. Azoarcus sp. CIB is able to 
degrade aromatic compounds both 
aerobically and anaerobically (20,22) and it 
has been used as a model organism to study 
the specific regulation of the benzoyl-CoA 
central pathways for the aerobic (box genes) 
and anaerobic (bzd genes) degradation of 
benzoate (20, 23-27).  
The Azoarcus sp. CIB bzd genes 
responsible for the anaerobic degradation of 
benzoate are clustered and consist of the PN 
promoter driven bzdNOPQMSTUVWXYZA 
catabolic operon and the bzdR regulatory 
gene (20). BzdR-mediated repression of PN 
is alleviated by the inducer molecule 
benzoyl-CoA, the first intermediate of the 
catabolic pathway (23,24). However, 
activity of the PN promoter also strictly 
requires the AcpR transcriptional activator 
– an orthologue of the E. coli Fnr global 
regulator – which specifically drives 
expression of the bzd catabolic operon in an 
oxygen-dependent manner (25). In addition 
to this dual repressor / activator control, the 
PN promoter is also subject to control by the 
benzoyl-CoA dependent BoxR repressor – a 
BzdR paralog that regulates the expression 
of the box genes – indicating the existence 
of cross-regulation between the aerobic and 
anaerobic benzoate degradation pathways 
of Azoarcus sp. CIB (27).  
In our previous work we found that 
anaerobic expression of the bzd genes from 
the PN promoter is additionally subject to 
CCR control in response to organic acids 
such as succinate, malate and acetate (20), 
although the mechanism(s) underlying this 
level of control was not determined. In this 
work we report the characterization of 
AccR as a response regulator that mediates 
anaerobic CCR control on the PN promoter. 
Based on our finding that AccR exerts 
anaerobic CCR control on central pathways 
for catabolism of other aromatics in 
Azoarcus sp. CIB, AccR constitutes the first 
master regulator described that controls 
CCR of anaerobic catabolism of aromatic 
compounds in bacteria. Because of the 
existence of AccR orthologs within the 
genomes of closely related 
Azoarcus/Thauera strains, we suggest that 
AccR is likely the global mediator of CCR 
control for anaerobic assimilation of 
aromatic compounds in this group of β-
proteobacteria.  
 
EXPERIMENTAL PROCEDURES 
 Bacterial Strains, Plasmids and 
Growth Conditions-Bacterial strains and 
plasmids used are listed in Table 1. 
Plasmids were constructed by standard 
molecular techniques (35) with the fidelity 
of all PCR-derived DNA (Table 2) verified 
by sequencing. E. coli cells were routinely 
grown at 37ºC in Lysogeny broth (LB) 
medium (35). When required, E. coli 
AFMCPN was grown aerobically or 
anaerobically (using 10 mM nitrate as 
terminal electron acceptor) at 30ºC in M63 
minimal medium (36), supplemented with 
0.1 mg/ml thiamine and 20 mM glycerol as 
the carbon source. Azoarcus strains were 
similarly grown aerobically or 
anaerobically at 30ºC in MC medium 
containing the indicated carbon source(s) as 
described previously (20). Where 
appropriate, antibiotics were added at the 
following concentrations: ampicillin (Ap, 
100 µg/ml), kanamycin (Km, 50 µg/ml), 
gentamicin (Gm, 7.5 μg/ml), and 
streptomycin (Sm, 50 µg/ml). An AccR null 
derivative of Azoarcus sp. CIB was 
generated by homologous recombination 
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using the R6K-based suicide plasmid 
pKNG101∆accR (Table 1) that allows 
positive selections of double site 
recombinants using the sacB gene of 
Bacillus subtilis (31). Conjugation of 
pKNG101∆accR from replication-
permissive E. coli SM10 λpir was used to 
introduce the plasmid into Azoarcus sp. 
CIB. Derivatives containing first site 
recombinants were selected on 
streptomycin-containing MC medium with 
10 mM glutarate as the sole carbon source. 
Second site recombination was selected by 
growth on the same medium supplemented 
with 5% sucrose. Correct allelic exchange 
in sucrose resistant and streptomycin 
sensitive derivatives was verified using 
primers 5´AccRmut (BamHI) and 
3’AccRmut(SpeI) (Table 2).  
 
 Sequence Analyses and Molecular 
Modelling-The nucleotide sequence of the 
accR gene of Azoarcus sp. CIB has been 
submitted to the GenBank with accession 
number KF233996. Pairwise and multiple 
sequence alignments of AccR-like proteins 
were made with the CLUSTALW (37) 
program at the EMBL-EBI server 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/
). Phylogenetic analysis, carried out 
according to Kimura´s two-parameter 
method (38), was reconstructed using the 
neighbour-joining method (39) PHYLIP 
program (40).  
 β-Galactosidase Assays-The β-
galactosidase activities from promoter-lacZ 
reporter fusions were measured with 
permeabilized cells, when cultures reached 
mid-exponential phase, as described by 
Miller (36). 
 
 Purification of AccR Derivatives-
His-tagged AccR derivatives, all with a 13 
amino acid (MRGSHHHHHHGIL) N-
terminal fusion, were expressed from the 
isopropyl-1-thio-ß-D-galactopyranoside 
(IPTG) inducible T5 promoter of pQE32 
expression vector (His6AccR from pQE32-
His6AccR, His6AccRD60E from pQE32-
His6AccRD60E, and His6CAccR from 
pQE32-His6CAccR; Table 1). Proteins were 
purified from E. coli M15 that additionally 
harboured pREP4, a LacI expression 
plasmid that aids IPTG-dependent 
expression. Cultures were grown at 37°C 
until the mid-exponential growth phase in 
LB containing appropriate antibiotics and 
then expression was induced by the 
addition of IPTG (0.1 mM). After a further 
5 hours incubation, cells were harvested 
from 1 litre of culture at 4°C, resuspended 
in 25 ml lysis buffer [50 mM NaH2PO4, pH 
8.0, 300 mM KCl, 20 mM imidazol] and 
disrupted by passage through a French 
press (Aminco Corp.) operated at a pressure 
of 20,000 p.s.i. Cell lysates were clarified 
by centrifugation (26,000 x g for 25 min at 
4°C) prior to loading on nickel-
nitrilotriacetic acid-agarose columns 
(Qiagen) equilibrated with lysis buffer. 
Columns were washed at 4°C with 50 
volumes of lysis buffer and the His-tagged 
proteins subsequently eluted with elution 
buffer [50 mM NaH2PO4, pH 8.0, 300 mM 
KCl, 75 mM imidazol]. Peak fractions were 
pooled, dialyzed at 4°C into modified FP 
buffer [20 mM Tris-HCl, pH 7.5, 5% 
glycerol, and 50 mM KCl], and stored as 
independent aliquots at -20 °C. 
 
 In vitro Phosphorylation of AccR 
Derivatives-AccR and its derivatives were 
phosphorylated by treatment with 20 mM 
carbamoyl phosphate in phosphorylation 
buffer [20 mM Pipes, 10 mM magnesium 
acetate, 10 mM KCl, 170 mM NaCl, and 
5% (vol/vol) glycerol, pH 7.5] for 90 min at 
28°C. 
 
 Mass Spectrometry Analyses-Mass 
spectrometry experiments with the AccR 
and AccR-P proteins (20 μM) were 
performed on an Autoflex III MALDI-
TOF-TOF instrument (Bruker Daltonics, 
Bremen, Germany) with a smartbeam laser. 
Spectra were acquired using a laser power 
just above the ionization threshold. Samples 
were analysed in the positive ion detection 
and delayed extraction linear mode. 
Typically, 1000 laser shots were summed 
into a single mass spectrum. External 
calibration was performed using bovine 
albumin (Sigma), covering the range from 
30.000 to 70.000 Da. A saturated solution 
of sinapinic acid in 3:1 water/acetonitrile 
and 0.1% trifluoroacetic acid was used as 
the matrix. For sample preparation, the 
sample solution and the matrix were 
premixed (1:1, v/v) and then 1 µl of the 
mixture was spotted on the stainless steel 
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target and allowed to dry at room 
temperature. 
 
 Analytical Ultracentrifugation 
Methods-Analyses were performed using 
several protein concentrations (from 5 to 40 
μM) equilibrated with 20 mM Tris HCl pH 
7.5 / 50 mM KCl / 5% glycerol buffer. 
Sedimentation velocity runs (48,000 rpm at 
20°C) were carried out in an XL-I 
analytical ultracentrifuge (Beckman-Coulter 
Inc.) equipped with UV-Visible optic 
detection system, using an An50Ti rotor 
and 12 mm double sector centrepiece. 
Sedimentation profiles were registered 
every 1–5 min at 280 nm in the experiments 
with His6-AccR and His6-AccR-P, and 235 
nm in the experiments with His6-CAccR. 
Sedimentation coefficient distributions 
were calculated by least squares boundary 
modelling of sedimentation velocity data 
using the c(s) method (41), as implemented 
in the SEDFIT program. These s values 
were corrected to standard conditions 
(water at 20°C, and infinite dilution) using 
the SEDNTERP program (42) to obtain the 
corresponding standard s values (s20,w). 
Sedimentation equilibrium assays were 
carried out using the same experimental 
conditions and instrument as in the 
sedimentation velocity experiments, with 
speeds ranging from 5,000 to 15,000 rpm 
(depending upon the sample analyzed) and 
at several wavelengths (235, 260, 280, and 
290 nm) with short columns (85–95 μl). 
After each equilibrium scan, a high speed 
centrifugation run (40,000 rpm) was 
performed to estimate the corresponding 
base-line offset. The measured low speed 
equilibrium concentration (signal) gradients 
of His6-AccR, His6-AccR-P and His6-
CAccR were fitted using an equation that 
characterizes the equilibrium gradient of an 
ideally sedimenting solute (using a 
MATLAB program, kindly provided by Dr. 
Allen Minton, National Institutes of Health) 
to obtain the corresponding buoyant signal 
average molecular weight.  
 
 Gel Retardation  Assays-Gel 
retardation reaction mixtures (9 μl) 
contained FP buffer [20 mM Tris-HCl, pH 
7.5, 10% glycerol, 2 mM β-
mercaptoethanol, 50 mM KCl], 0.05 nM 
32P-labelled DNA probe, 250 μg/ml bovine 
serum albumin, 50 μg/ml herring sperm 
(competitor) DNA, and the indicated 
concentration of purified protein. After 
incubation for 20 min at 30ºC, samples 
were analyzed by electrophoresis using 5% 
polyacrylamide gels buffered with 0.5 x 
TBE (45 mM Tris-borate, 1 mM EDTA). 
Dried gels were subsequently imaged using 
Hyperfilm MP (Amersham Biosciences). 
Radiolabelled DNA probes [PN (376 bp), 
PN2 (162 bp), PN3 (93 bp) PN2mut (165 bp), 
PB1 (251 bp), and PD (234 bp)] were 
generated by PCR amplification (Table 2). 
For all but the PB1 probe, 32P was 
incorporated by the use of a primer 5’-end 
labelled with phage T4 polynucleotide 
kinase and [γ-32P]ATP (3000 Ci/momol, 
Perkin-Elmer Life Sciences). For the PB1 
probe, 32P was incorporated by digestion of 
the PCR derived DNA with EcoRI and 
subsequent filling in of the resulting 
overhang end with [α-32P]dATP (6000 
Ci/mmol; Perkin Elmer) and the Klenow 
fragment of E. coli DNA polymerase I. 
 
 DNaseI Footprinting Assays-
DNaseI footprinting reactions (15 µl) in FP 
buffer contained 2 nM radiolabelled PN 
probe (see above), 1 mg/ml bovine serum 
albumin, and the indicated concentration of 
in vitro phosphorylated His6-AccR (AccR-
P). Reactions were incubated for 20 min at 
25ºC, prior to addition of 3 µl (0.05 units) 
of DNase I solution [prepared in 10 mM 
CaCl2, 10 mM MgCl2, 125 mM KCl, and 
10 mM Tris-HCl, pH 7.5]. After 20 s 
incubation at 37°C, reactions were 
quenched by the addition of 180 µl of a 
solution containing 0.4 M sodium acetate, 
2.5 mM EDTA, 50 µg/ml calf thymus 
DNA, and 0.3 µg/ml glycogen. DNA 
fragments were phenol extracted, 
precipitated and analysed as previously 
described (23). An A+G reaction (43) was 
carried out with the same fragment. Images 
were obtained as described for gel 
retardation assays. 
 
  In vitro Transcription Experiments-
Multiple-round in vitro transcription 
reactions (50 μl) were performed essentially 
as previously described (25) in a buffer 
consisting of 40 mM Tris-HCl pH 7.5, 100 
mM KCl, 10 mM MgCl2, 0.1 mM bovine 
serum albumin and 10 mM dithiothreitol. 
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Reactions contained 5 nM of supercoiled 
plasmid pJCD-PN as the DNA template, 50 
nM E. coli σ70-RNA polymerase (1U/μl; 
USB), 200 nM His6-Fnr* activator (a 
constitutively active Fnr derivative that is 
able to promote transcription in the 
presence of oxygen) (25,44) and different 
concentrations of purified AccR or AccR-P 
proteins. Reactions were equilibrated for 10 
min at 37ºC prior to initiation of 
transcription by the addition of nucleotides 
[final concentrations: 500 nM of ATP, 
CTP, and GTP; 50 nM UTP; and 1μCi of 
[α-32P]UTP (3,000 mCi/mmol; Perkin 
Elmer)]. After incubation for 20 min at 
37°C, reactions were terminated by the 
addition of an equal volume of a solution 
containing 50 mM EDTA, 350 mM NaCl 
and 0.5 mg/ml of carrier tRNA. Ethanol 
precipitated transcripts were dissolved in 
loading buffer (7 M urea, 1 mM EDTA, 0.6 
M glycerol, 0.9 mM bromophenol blue, and 
1.1 mM xylene cyanol), resolved by 
electrophoresed on a denaturing 7 M urea / 
4% polyacrylamide gel, and visualized by 
autoradiography. 
 
 Real-time RT-PCR Assays-Total 
RNA was extracted and DNase I treated 
using reagents provided with the RNeasy 
Mini Kit (Qiagen) according to the 
manufacturer instructions. The 
concentration and purity of the RNA 
samples were assessed using an ND1000 
spectrophotometer (Nanodrop 
Technologies) according to the 
manufacturer´s protocols. Synthesis of total 
cDNA was performed in 20 µl reactions 
containing 1 µg RNA, 0.5 mM of each 
dNTP, 200 U of SuperScript II reverse 
transcriptase (Invitrogen), and 5 µM of 
random hexamers in the buffer provided by 
the manufacturer. Samples were initially 
heated at 65ºC for 5 min and then incubated 
at 42°C for 2 h. Reactions were terminated 
by incubation at 70°C for 15 min and the 
cDNA further purified using Geneclean 
Turbo kit (MP Biomedicals). An IQ5 
Multicolor Real-Time PCR Detection 
System (Bio-Rad) was used for real-time 
PCR of triplicate samples. Reactions (25 μl) 
containing 5 ng cDNA, 0.2 μM of two 
target specific primers, and 12.5 μl SYBR 
Green Mix (Applied Biosystems). Primer 
pairs used to amplify transcripts from the 
PD and PN promoters and the transcript of 
the dnaE gene (encoding the α-subunit of 
DNA polymerase III) as an internal control 
to normalize the sample data are given in 
Table 2. Amplifications were carried with 1 
denaturation cycle (95°C for 4 min), 
followed by 30 cycles of amplification 
(95°C for 1 min; 60°C for 1 min; 72°C for 
30 s). After amplification, melting curves 
were generated to confirm amplification of 
a single product. For relative quantification, 
a calibration curve was constructed for each 
amplicon by using five-fold serial dilutions 
of Azoarcus sp. CIB genomic DNA ranging 
from 2.5 ng to 1.6 x10-6 ng. These standard 
curves were used to extrapolate the relative 
abundance of the cDNA targets within the 
linear range of the curve. Results were 
normalized relative to those obtained for the 
dnaE internal control.  
 
 
RESULTS  
 
 The accR Gene Is Required for 
CCR Control of the bzd Genes in Azoarcus 
sp. CIB-In silico analysis of the 
unpublished draft Azoarcus sp. CIB 
genome sequence identified a gene – 
hereafter referred to as accR (aromatic 
catabolic control regulator; accession 
number KF233996) – whose product shows 
47% amino acid sequence identity with the 
response regulator BphQ involved in CCR 
control of the biphenyl degradation 
pathway in Acidovorax sp. KKS102 (7). 
Orthologs of accR are also found in the 
genomes of other β-proteobacteria Azoarcus 
and Thauera strains (Supplemental Fig. 
S1). These observations prompted us to test 
AccR as a potential candidate for CCR 
control of the assimilation of aromatic 
compounds in Azoarcus sp. CIB. To this 
end we generated an AccR null derivative 
(Azoarcus sp. CIBΔaccR, Table 1), and 
measured the activity of the PN promoter, 
which drives the anaerobic expression of 
the bzd genes, in comparison to PN activity 
in the wild type strain. Transcripts from PN 
were monitored by real-time RT-PCR using 
RNA extracted from cultures grown 
anaerobically at the expense of benzoate 
alone (control condition) or benzoate plus 
succinate (CCR condition). As shown in 
Fig. 1, both strains exhibited similar levels 
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of PN activity when grown on benzoate, but 
the AccR null mutant was unable to exert 
CCR control in response to succinate – a 
defect that could be complemented by 
introduction of plasmid pBBR5AccR 
(Table 1) carrying accR under control of the 
Plac promoter. Hence, these results support 
the idea that AccR acts to repress the PN 
promoter under CCR conditions. 
 
 AccR Possess in vitro Properties of 
Response Regulators-Sequence 
comparisons indicated that AccR belongs to 
the FixJ/NarL family of response regulators 
(45-47). AccR exhibits the typical two-
domain architecture of this class of 
proteins, consisting of an N-terminal 
domain (NAccR; residues 1-122) and a C-
terminal region (CAccR; residues 145-212) 
connected by a 23-residues long linker 
(Supplemental Fig. S1A). The NAccR 
domain contains the highly conserved 
receiver (REC) motif (residues 20-122) 
(Supplemental Fig. S1A), that is involved in 
phosphorylation and dephosphorylation 
reactions of response regulators (48). The 
CAccR domain contains a NarL/FixJ helix-
turn-helix (HTH) DNA-binding motif 
(residues 162-189) responsible for 
interaction with the DNA (Supplemental 
Fig. S1A).  
 To determine whether AccR 
behaves as a typical response regulator in 
vitro, we expressed and purified a N-
terminally His-tagged version of the AccR 
protein (His6-AccR). Response regulators 
usually receive a phosphate group from a 
cognate histidine kinase in intact cells; 
however, REC motifs can also catalyze 
autophosphorylation using small 
phosphodonor molecules such as carbamoyl 
phosphate or acetyl phosphate (48). Hence, 
we analysed purified AccR before and after 
treatment with carbamoyl phosphate. Mass 
spectrometry analysis of untreated AccR 
revealed a single peak that corresponds to 
the theoretical mass of monomeric AccR 
(24,629 Da; Fig. 2A). When carbamoyl 
phosphate treated AccR was similarly 
analysed, two peaks were resolved – one 
corresponding to the unadorned monomer 
and the other compatible with the addition 
of a phosphate group (24,708.6 Da; Fig. 
2B). We conclude from these results that 
AccR becomes phosphorylated (AccR-P) in 
the presence carbamoyl phosphate.  
Analysis of the REC motif 
suggested that autophosphorylation of the 
AccR protein would occur at the highly 
conserved Asp60 residue that is located at 
the C-terminal end of β3-strand 
(Supplemental Fig. S1A). To 
experimentally verify this supposition, we 
purified a His-tagged mutant variant with 
Asp60 substituted to Glu (AccRD60E), a 
substitution that serves as a phospho-mimic 
in some response regulators (49,50). In 
contrast to the wild-type protein, 
AccRD60E exhibited no change in mass 
upon treatment with carbamoyl phosphate, 
supporting the idea that Asp60 is the target 
residue for AccR autophosphorylation. 
 
 AccR Undergoes a Monomer-to-
Dimer Shift upon Phosphorylation-
Phosphorylation of some response 
regulators results in a change in their 
oligomeric state (51). To determine if such 
a change occurs with AccR, we performed 
analytical ultracentrifugation analyses with 
different concentrations (5 to 40 μM) of 
untreated and carbamoyl phosphate treated 
AccR. Sedimentation velocity analysis of 
10 μM of untreated AccR revealed a single 
species with an s value of 1.5 S (Fig.  2C). 
Carbamoyl phosphate treatment resulted in 
two species of similar abundance, one with 
an s value of 1.5 S and another one with an 
s value of 2.1 S (Fig.  2D), suggesting that 
~50% of AccR becomes phosphorylated 
under the experimental conditions used.  
The molecular weight of the 1.5 S 
species, as measured by sedimentation 
equilibrium (24,000 +/- 500 Da), is 
compatible with the mass of the AccR 
monomer (Fig. 2E, squares). However, 
since the frictional ratio f/f0 of untreated 
AccR was 1.7, the shape deviates from that 
expected for a globular protein and suggest 
an elongated monomer. Sedimentation 
equilibrium experiments of the carbamoyl 
phosphate-treated AccR sample indicated a 
molecular mass (38,500+/- 400 Da) 
between that of a monomer and a dimer of 
the protein (Fig. 2E, circles), which is in 
agreement with the co-existence of 
approximately equal amounts of the 1.5 S 
(monomer) and 2.1 S (dimer) species within 
this preparation (Fig. 2D). Together, these 
8 
 
results demonstrate that unmodified AccR 
exists primarily as an elongated monomer, 
while phosphorylation induces a monomer-
to-dimer transition but does not 
significantly change the global shape of the 
protein that retains a frictional ratio f/f0 of 
1.7.  
 
 DNA Binding by AccR Is 
Phosphorylation Dependent-Having 
established that AccR undergoes a 
phosphorylation-dependent conformational 
change (Fig. 2) and influences expression 
of bzd genes through the PN promoter (Fig. 
1), we next determined the ability of AccR 
to bind to DNA. For this we used a 376-bp 
DNA fragment spanning from -293 to +83 
with respect to the transcription start site of 
the PN promoter (PN probe) in gel-
retardation assays. The AccR protein was 
unable to bind to the PN probe unless 
phosphorylated by prior carbamoyl 
phosphate treatment (Fig. 3A and B), while 
the Asp60 to Glu phospho-mimic 
substitution in AccRD60E rendered the 
protein DNA-binding competent in its non-
phosphorylated state (Fig. 3C). These 
results show that the DNA binding capacity 
of AccR is dependent on its phosphorylated 
state, which can be mimicked by an Asp60 
to Glu substitution. Because 
phosphorylation induces a monomer-to-
dimer transition, it appears likely that AccR 
binds DNA primarily as a dimer. 
 
 AccR Binds to Palindrome 
Operator Sites within PN to Confer CCR 
Control-To further characterize the DNA 
binding sites of AccR-P within the PN 
promoter we performed DNase I 
footprinting assays. As shown in Fig. 4A, 
AccR-P protected a DNA region spanning 
from position -34 to -153 with respect to 
the transcription start site of the PN 
promoter. This protected region contains 
two repetitions of the palindromic sequence 
(ATGCA-N6-TGCAT) – denoted OR1 
(from -67 to -82) and OR2 (from -130 to -
145), see Fig. 4B. To determine if AccR-P 
was able to recognize the two palindromic 
regions independently, we used two probes, 
PN2 that spans OR1 and PN3 that spans OR2 
(Fig. 4B), in gel-retardation assays. AccR-P 
bound to both probes with an affinity 
similar to that observed with the complete 
PN probe (compare Fig. 4C and D, with Fig. 
3B), indicating that AccR-P is able to 
recognize and bind to two different operator 
regions within the PN promoter. To verify 
the role of the ATGCA-N6-TGCAT 
palindrome in AccR-binding to PN, we 
constructed a mutant derivative of the PN2 
probe (PN2mut) in which the left-half site of 
OR1 (ATGCA) was replaced by the 
sequence CCCTG. As shown in Fig. 4E, 
AccR-P was unable to bind to the PN2mut 
probe. Similarly, AccR-P was unable to 
bind a truncated PN2 probe lacking the left-
half site of OR1 (data not shown). 
The results above demonstrate that 
AccR-P independently binds to two 
palindromic operator regions within the PN 
promoter. To confirm that the AccR 
operator regions are the ones responsible of 
the carbon catabolite control of PN, we 
constructed a truncated PN promoter that 
lacks the AccR binding regions (PN1; -61 to 
+79) in a PN1::lacZ fusion reporter plasmid 
and compared its activity to that of an 
otherwise identical wild type PN::lacZ 
reporter plasmid in Azoarcus sp. CIB. As 
anticipated, the PN1::lacZ fusion was 
essential immune to CCR control in 
response to succinate (Fig. 4F). 
 
 AccR Acts as a Repressor of the PN 
Promoter in vitro-Our in vivo experiments 
(Figs. 1 and 4F) suggested a repressor role 
for AccR on transcription from the PN 
promoter, which is consistent with the 
location of the AccR-P binding region 
spanning -35 to -153 (Fig. 4). To confirm 
this hypothesis, we performed in vitro 
transcription assays using a supercoiled 
DNA template bearing the PN promoter. 
Within these assays, activity from PN was 
elicited by constant concentrations of RNA 
polymerase and the Fnr* activator – an E. 
coli homolog of the AcpR activator of PN 
that retains activity in the presence of 
oxygen (25). The effect of different 
concentrations of AccR or AccR-P on PN 
output was then assessed. Whereas the 
formation of the expected 184-nucleotides 
transcript due to the activity of the PN 
promoter was unperturbed by the presence 
of AccR (Fig. 5, lanes 5 to 7), levels of this 
transcript decreased in the presence of 
increasing amounts of AccR-P (Fig. 5, 
lanes 2 to 4). These data confirm the 
9 
 
repressor role of AccR and demonstrate that 
its inhibitory action on PN activity is strictly 
dependent on the phosphorylated status of 
AccR.  
 
 CAccR Functions as an 
Independent Monomeric DNA Binding 
Domain-As outlined in the preceding 
sections, Asp60 within the REC motif of the 
NAccR domain is involved in 
autophosphorylation and CAccR contains 
the NarL/FixJ helix-turn-helix (HTH) 
DNA-binding motif predicted to mediate 
DNA binding. To determine if CAccR 
could function independently in this 
capacity, we purified a His-tagged version 
of CAccR (His6-CAccR) and monitored its 
DNA binding capacity in gel-retardation 
assays using the PN probe (as in Fig. 3). The 
data in Fig. 6A demonstrate that CAccR 
binds to the PN probe in a concentration-
dependent manner, experimentally 
verifying that this domain functions as an 
independent DNA binding domain.  
 Because phosphorylation of AccR 
provokes a monomer-to-dimer transition, 
we also determined the oligomeric status of 
CAccR as previously described for full 
length AccR. Sedimentation velocity 
experiments revealed a single species of 
CAccR with an s value of 1.1 S (Fig. 6B). 
The molecular weight of the 1.1 S species, 
as measured by sedimentation equilibrium 
of CAccR at different concentrations, is 
compatible with the mass of a monomer 
(Fig. 6C). We conclude from this data that 
under our experimental conditions, DNA-
binding proficient CAccR is a monomer in 
solution. As expanded upon in the 
discussion, this suggests that dimerization 
of AccR after phosphorylation is carried out 
through the N-terminal domain, and that 
dimerization is not a prerequisite for DNA 
binding per se. 
 
 AccRD60E Acts as a Super-
repressor-The Asp60 to Glu substitution 
renders AccR constitutively active (i.e. 
phosphorylation independent) in terms of 
its DNA binding capacity (Fig. 3C). 
Therefore, we were interested to test if it 
also exhibited constitutive repressor activity 
in vivo. To this end we used the 
heterologous E. coli AFMCPN strain, which 
carries a PN::lacZ translational fusion 
integrated into its chromosome (Table 1) 
and would be expected to lack a histidine 
kinase capable of phosphorylating AccR. 
Similar activities from the PN promoter 
were found in E. coli AFMCPN harbouring 
either a vector control or a plasmid 
expressing AccR, while PN activity was 
reduced ~4-fold in the strain harbouring a 
plasmid expressing AccRD60E (Fig. 7A).  
The results outlined above 
demonstrate that the unphosphorylated 
AccRD60E protein is able to effectively 
bind and repress PN promoter activity in E. 
coli. To test if this was also the case in 
Azoarcus sp. CIB, we monitored the effect 
of expressing AccRD60E on the ability of 
the AccR null strain to grow anaerobically 
at the expense of benzoate. Whereas 
Azoarcus sp. CIBΔaccR was able to grow 
on benzoate (Fig. 7B, triangles), Azoarcus 
sp. CIBΔaccR harbouring a plasmid 
expressing AccRD60E protein could not 
(Fig. 7B, squares). These results strongly 
support the idea that AccRD60E is 
constitutively active in Azoarcus and 
behaves as a super-repressor of the bzd 
cluster through inhibiting the activity of the 
PN promoter. 
  
 AccR Is a Master Regulator 
Controlling All Central Pathways for the 
Anaerobic Catabolism of Aromatics in 
Azoarcus sp. CIB-In addition to the bzd-
pathway, the Azoarcus sp. CIB mbd 
pathway for anaerobic assimilation of 3-
methylbenzoate/m-xylene is also subject to 
CCR control in response to some organic 
acids (34). To explore whether AccR also 
controls expression of the mbd genes, we 
monitored the activity of the PB1 promoter 
that drives expression of the mbd genes 
using a PB1::lacZ translational fusion 
reporter plasmid. While succinate caused 
inhibition of PB1 promoter activity in the 
wild-type CIB strain, no inhibition of PB1 
activity was observed in the AccR null 
strain (Fig. 8A). A direct interaction 
between AccR-P with the PB1 promoter was 
confirmed by gel-retardation (Fig. 8B). 
Taken together, these results demonstrated 
that AccR is also involved in succinate 
mediated anaerobic CCR control of the mbd 
genes in Azoarcus sp. CIB.  
 A third distinct central pathway for 
anaerobic degradation of aromatics in 
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Azoarcus sp. CIB is the hbd-pathway 
devoted to 3-hydroxybenzoate catabolism 
(22). To determine whether AccR also 
controls the expression of the genes for 3-
hydroxybenzoate catabolism, Azoarcus sp. 
CIBΔaccR harbouring a plasmid expressing 
wild type AccR or AccRD60E were grown 
anaerobically in minimal medium 
containing 3-hydroxybenzoate as the sole 
carbon source. As was the case for growth 
at the expense of benzoate (Fig. 7B), cells 
expressing AccR were able to grow on 3-
hydroxybenzoate whilst those expressing 
the constitutively active AccRD60E super-
repressor could not. Hence, these results 
strongly suggests that the genes responsible 
of the anaerobic catabolism of 3-
hydroxybenzoate are also negatively 
controlled by AccR. Together with the 
impact of AccR on the bzd- and mbd-
pathways, the results provide additional 
support for the idea that AccR is a master 
regulator of the anaerobic catabolism of 
aromatic compounds in Azoarcus sp. CIB.  
 
 The AccR-Mediated CCR Control is 
Only Operational under Anaerobic Growth 
Conditions-To explore whether AccR also 
mediates CCR control of aerobic 
degradation of aromatic compounds, we 
used real-time RT-PCR to monitor the 
activity of the PD promoter, which drives 
the expression of the box genes for the 
aerobic degradation of benzoate in 
Azoarcus sp. CIB (27). When the cells were 
grown aerobically in benzoate, succinate 
significantly inhibited the activity of PD 
promoter; however, this inhibition was not 
attributable to AccR since it was also 
observed in the AccR null strain (Fig. 9A). 
Since we have shown previously that the 
box genes can be also expressed under 
anaerobic growth conditions (27), we tested 
whether such anaerobic expression was 
controlled by AccR. In contrast to the 
results obtained under aerobic growth 
conditions, when the cells were grown 
anaerobically in the presence of benzoate, 
succinate-mediated inhibition was found in 
the wild-type but not the AccR null strain 
(Fig. 9B). As is the case for the PN and PB1 
promoters, the PD promoter was bound by 
AccR-P in gel-retardation assays (Fig. 9C) 
and also contains a sequence that bears 
homology to the ATGCA-N6-TGCAT motif 
identified on the basis of AccR-P binding to 
PN (Fig. 9D). Taken together these results 
indicate that the AccR regulatory circuit 
operates through binding to common DNA 
motifs and is only operational under 
anaerobic growth conditions. 
 
 
DISCUSSION 
 
 When faced with a mixture of 
alternative carbon sources, bacteria usually 
strategically utilize the substrate that yields 
the highest energy return. The utilization of 
preferred carbon sources is controlled by 
global regulatory mechanisms, termed 
CCR, which depends on the energy status 
of the cell and that also responds to other 
environmental conditions, such as growth 
temperature and carbon source 
concentrations, thus conferring to the 
bacteria with a competitive advantage in 
natural environments (4,52,53). Aromatic 
compounds usually constitute a secondary 
(non preferred) carbon source for many 
bacteria. Diverse mechanisms underlie 
CCR control in aerobic metabolism of 
aromatic compounds (6-11, 16-18). Here 
we report the first known mechanism that 
accounts for CCR control of anaerobic 
catabolism of aromatic compounds in 
bacteria – namely the transcriptional 
repressor AccR of Azoarcus sp. CIB. Our 
evidence that AccR can be considered as a 
master regulator of anaerobic catabolism of 
aromatics is based on the finding that this 
protein controls expression of all known 
central anaerobic aromatic catabolic 
pathways of this strain. These include the 
bdz-pathway for dissimilation of benzoate, 
the 3-methybenzoate mbd-pathway, the 3-
hydroxybenzoate hbd-pathway, and the 
benzoate box-pathway as expressed under 
anaerobic growth conditions (Figs. 1, 4F, 8, 
9). Because expression of the box-pathway 
is only affected by the lack of AccR under 
anaerobic but not aerobic conditions (Fig. 
9), we suggest that the AccR circuitry is 
only operational under anaerobic growth 
conditions. 
 In silico analysis assigns AccR to 
the FixJ/NarL family of response regulators 
(Supplemental Fig. S1) whose members 
participate in the control of a wide variety 
of biological functions (45-47). We found 
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that, like some previously characterised 
members of this family [e.g. FixJ, OmpR, 
PhoB and StyR (54-56)], phosphorylation 
of AccR to AccR-P with high-energy small 
molecule phosphodonors (e.g., carbamoyl 
phosphate) (Fig. 2B) triggers a monomer-
to-dimer transition (Fig. 2D and E); 
however, this reconfiguration does not 
change the apparent overall elongated shape 
of the AccR protomers. Under our in vitro 
conditions, only ~50% phosphorylation of 
AccR was achieved (Fig. 2B and D). This 
could be attributable to partial 
phosphorylation or spontaneous 
dephosphorylation; alternatively, it may be 
due to an innate phosphatase activity of 
AccR. In this respect, it is well established 
that despite extensive structural and 
chemical similarities, the half life of the 
phosphorylated state of response regulators 
varies extensively (from seconds to hours) 
depending on both their innate auto-
phosphorylation and auto-
dephosphorylation kinetics (42).  
In addition to subunit configuration, 
phosphorylation controls the ability of 
AccR to bind DNA (Fig. 3) and its capacity 
to cause repression of promoter output in in 
vitro transcription assays (Fig. 5). 
Conversely, substitution of the highly 
conserved Asp60 residue of the N-terminal 
REC motif of AccR to a phosphor-mimic 
Glu residue (AccRD60E) renders the 
protein constitutively active 
(phosphorylation-independent) both in 
terms of its DNA binding ability (Fig. 3C) 
and its capacity to repress promoter output 
in intact cells (Fig. 7), suggesting that Asp60 
is the target residue of phosphorylation. 
Thus, AccR behaves like a typical response 
regulator that upon activation represses 
promoter output both in vivo and in vitro. 
The lack of anaerobic growth in benzoate of 
an AccR null derivative of Azoarcus sp. 
CIB expressing the AccRD60E protein 
(Fig. 7B), is consistent with the role of this 
mutant regulator as a super-repressor of the 
bzd central pathway.  
The phosphorylation-triggered 
monomer-to-dimer transition of AccR 
suggests that the AccR-P would bind DNA 
as a dimer – a configuration consistent with 
our identification of the inverted repeat 
ATGCA-N6-TGCAT as the AccR DNA 
binding site within the PN promoter. The PN 
promoter harbours two of these sites 
(denoted OR1 and OR2) which can each be 
bound independently by AccR with 
approximately equal affinity (Fig. 4), while 
the PB1 and PD promoters, which are also 
targeted by AccR (Figs. 8 and 9), possess 
one copy of this motif (Fig. 9D). A 
truncated PN promoter that lacks the AccR 
binding regions (PN1) did not show 
succinate dependent CCR control (Fig. 4F), 
which illustrates how a rational design of a 
target promoter can be an interesting 
strategy to circumvent CCR in bacteria. The 
location of the AccR binding region within 
PN (spanning position -35 to -153 relative to 
the transcriptional start site) is consistent 
with the observed repressor role of AccR. 
We can envisage two plausible and non-
mutually exclusive means by which DNA 
binding by AccR-P could inhibit promoter 
output: i) inhibition of closed complex 
formation by occluding RNA polymerase 
and/or ii) inhibition of open complex 
formation by preventing binding of the 
AcpR activator whose operator region 
spans from -42.5 to -39.5 (25). 
In contrast to the apparent 
dimerization-dependent DNA-binding of 
intact AccR-P, the DNA-binding proficient 
C-terminal domain of AccR (CAccR) is 
monomeric in solution (Fig. 6). These 
findings suggest that i) dimerization per se 
is not a prerequisite for DNA binding, and 
ii) that dimerization is carried out through 
the N-terminal domain, as exemplified by 
NarL (46). Further, the results suggest a 
regulatory scenario in which 
phosphorylation of Asp60 of AccR alleviates 
inter-domain repression mediated by the N-
terminal domain to allow reconfiguration to 
a DNA-binding proficient configuration. 
Since linker regions can be crutial for 
correct inter-domain communication (57), it 
is plausable that the long linker region of 
AccR may play a role in transmitting the 
phosphorylation-dependent conformational 
changes (from the NAccR domain to the 
CAccR domain) to result in de-repression 
and thus activation of its capacity to bind to 
target promoters. However, like a potential 
auto-phosphatase activity of AccR, these 
mechanistic possibilities require 
experimental verification. 
As described in the introduction, 
amongst the diverse proteins that have been 
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found to be involved in CCR control of 
aerobic catabolism of aromatic compounds, 
only one – BphQ – is a response regulator. 
A search of accR homologs in bacterial 
genomes revealed the presence of AccR-
like proteins (amino acid sequence identity 
higher than 70%) encoded in the genomes 
of other Azoarcus and Thauera strains 
(Supplemental Fig. S1A). These AccR-like 
regulators cluster in a branch of the 
phylogenetic tree different to that of the 
BphQ-like regulators (Supplemental Fig. 
S1B), which suggests that both types of 
proteins, although evolutionary related, 
constitute different sub-groups of response 
regulators. In this respect it is worth noting 
that AccR from Azoarcus sp. CIB and 
BphQ from Acidovorax sp. KKS102 have 
completely different regulatory features: 
whereas BphQ is a transcriptional activator 
that binds its target DNA in the absence of 
phosphorylation (7), AccR is a repressor 
that requires phosphorylation in order to 
bind to a target operator that is completely 
different to that described for BphQ.  
Many β-proteobacteria Azoarcus 
and Thauera strains are able to 
anaerobically metabolise aromatic 
compounds. The presence of accR 
orthologs within their genomes raises the 
possibility that AccR constitutes a new 
global regulator that controls anaerobic 
carbon catabolite repression in this group of 
organisms. Our observation that the accR-
genes are always located adjacent to a gene 
that encodes a putative sensor histidine 
kinase strongly suggests that the latter 
would be responsible for maintaining AccR 
in its active phosphorylated state in the 
presence of preferred carbon sources such 
as succinate. The work presented here 
should greatly facilitate our future efforts 
aimed to characterize this predicted two-
component regulatory system and to 
decipher the environmental signals that 
trigger the activation/inactivation status of 
AccR.  
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FIGURE LEGENDS 
FIGURE 1. The accR gene is required for CCR control of the PN promoter. Azoarcus sp. 
CIB (CIB), its AccR null counterpart (CIBΔaccR), and CIBΔaccR harbouring plasmid 
pBBR5AccR that expresses AccR from the Plac promoter (CIBΔaccR/accR), were grown 
anaerobically in minimal medium supplemented with 3 mM benzoate (black bars) or a mixture 
of 3 mM benzoate and 0.4% succinate (white bars). Total RNA was isolated from cells grown 
until mid-exponential phase and the activity of the PN promoter (in arbitrary units) was 
measured by real-time RT-PCR. Graphed values are the average of three independent 
experiments +/- S.D.  
 
FIGURE 2. In vitro phosphorylation of AccR provokes a monomer-to-dimer transition. A 
and B, mass spectrometry (MALDI-TOF) of untreated His6-AccR (panel A) and His6-AccR 
preincubated with 20 mM carbamoyl phosphate (panel B). Molecular masses of the peaks 
corresponding to unphosphorylated (AccR) and phosphorylated (AccR-P) proteins are 
indicated. C and D, sedimentation coefficient distribution c(s) corresponding to 10 µM 
untreated His6-AccR (panel C) and carbamoyl phosphate treated His6-AccR (panel D) are 
represented in relation to the sedimentation coefficient (S). The peaks corresponding to the 
AccR and AccR-P species are indicated. The s value of the proteins did not change significantly 
with protein concentration over the range examined (5-40 μM). E, sedimentation equilibrium 
data of untreated (squares) and carbamoyl phosphate treated His6-AccR (circles). Best fit 
analysis assuming a theoretical protein monomer (solid line) or dimer (dashed line) is also 
shown. 
 
FIGURE 3. DNA binding by AccR is phosphorylation dependent. Gel-retardation analyses of 
the PN probe by AccR derivatives (0 to 12 µM) as described under "Experimental Procedures". 
A, assays with increasing concentrations of untreated His6-AccR protein (AccR). Free PN probe 
is indicated by an arrow. B, assays performed with increasing concentrations of carbamoyl 
phosphate treated His6-AccR (AccR-P). Free PN probe and the major PN/AccR-P complex are 
indicated by arrows. C, assays performed with increasing concentrations of His6-AccRD60E 
(AccRD60E). Free PN probe and the major PN/AccRD60E complex are indicated by arrows.  
 
FIGURE 4. AccR-P binds to two palindromic operator sequences within the PN promoter. 
A, DNase I footprinting analyses of the PN probe with 0 to 12 μM carbamoyl phosphate treated 
His6-AccR (AccR-P) as described under "Experimental Procedures". Lane AG shows an A+G 
Maxam and Gilbert sequencing reaction with the location of the -10 and -35 boxes and the 
transcription initiation site (+1) indicated to the left. The AccR-P protected region between 
positions -153 and -34 is highlighted by a bracket, with phosphodiester bonds mildly 
hypersensitive to DNase I cleavage indicated by asterisks. B, expanded view of the PN promoter 
sequence. Inferred -10 and -35 promoter elements and the transcription start site (+1) are 
indicated in italics. The ribosome-binding site (RBS) and the bzdN ATG initiation codon are 
underlined. The region protected by AccR-P (as under panel A) is boxed with the location of the 
palindrome operator sequences (OR1 and OR2) indicated by convergent arrows. Nucleotides 
corresponding to the PN2 and PN3 probes used in panels C and D are underlined with 
discontinuous and continuous lines, respectively. C to E, gel-retardation analyses of the 
indicated probes as under Fig. 3B. Gel-retardation assays were performed using increasing 
concentrations (0 to 12 μM) of carbamoyl phosphate treated His6-AccR (AccR-P). The free 
probes and the major DNA/AccR-P complexes are indicated by arrows. F, effect of succinate 
on the activity of the native PN promoter and the truncated PNI promoter that lacks the OR1 and 
OR2 operators. Azoarcus sp. CIB cells harbouring the PN::lacZ translational reporter plasmid 
pBBR5PN or the PNI::lacZ translational reporter plasmid pBBR5PNI were grown anaerobically in 
minimal medium containing 3 mM benzoate (black bars) or a mixture of 3 mM benzoate and 
0.2% succinate (white bars) until the mid-exponential phase. Values are the average of three 
independent experiments +/- S.D, and are graphed setting the β-galactosidase activities obtained 
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for each promoter in the absence of succinate (22000 and 2500 Miller units for PN and PNI, 
respectively) as 100%. 
 
FIGURE 5. AccR-P represses transcription from the PN promoter in vitro. Multiple-round in 
vitro transcription reactions, as detailed in "Experimental Procedures", contained 5 nM of 
supercoiled pJCD-PN plasmid DNA (which produces a 184-nucleotide mRNA from PN  and a 
105-nucleotide control mRNA), 40 nM of E. coli RNA polymerase, and 200 nM of the His6-
Fnr* activator. Reactions were carried out in the absence of AccR, or in the presence of 
increasing concentrations of phosphorylated His6-AccR (AccR-P) or unphosphorylated His6-
AccR (AccR).  
 
FIGURE 6. CAccR functions as an independent monomeric DNA binding domain. A, gel 
retardation analysis of the PN probe, as under Fig. 3A, using increasing concentrations (0 to 10 
μM) of His6-CAccR (CAccR). The free PN probe and the major PN/CAccR complex are 
indicated by arrows. B, sedimentation coefficient distribution c(s) corresponding to 10 µM His6-
CAccR is represented in relation to the sedimentation coefficient (S). The peak corresponding to 
the single His6-CAccR species detected is indicated. C, sedimentation equilibrium data of His6-
CAccR (circles) and best fit analysis assuming a theoretical protein monomer (solid line) or 
dimer (dashed line). 
 
FIGURE 7. The AccRD60E protein acts as a constitutive repressor of the PN promoter. A, 
effect of the AccRD60E protein on the activity of the PN promoter in E. coli AFMCPN cells that 
contain a chromosomal PN::lacZ fusion. Cells harbouring a plasmid expressing the AccRD60E 
(pIZAccRD60E), AccR (pIZAccSR), or a cognate vector control (C, pIZ1016), were grown 
anaerobically in glycerol-containing minimal medium until mid-exponential phase. Graphed 
values of β-galactosidase activities (in Miller units) are the average from three independent 
experiments +/- S. D. B, anaerobic growth of Azoarcus sp. CIBΔaccR (triangles) and Azoarcus 
sp. CIBΔaccR harbouring pIZAccRD60E (squares) in minimal medium containing 3 mM 
benzoate as the sole carbon source. 
 
FIGURE 8. AccR controls the activity of the PB1 promoter. A, Azoarcus sp. CIB (CIB) and 
Azoarcus sp. CIBΔaccR (CIBΔaccR) cells harbouring the PB1::lacZ reporter plasmid pIZPB1 
were grown anaerobically in minimal medium containing a mixture of 3 mM 3-methylbenzoate 
and 1 mM benzoate as a co-carbon source that does not cause CCR of the PB1 promoter (black 
bars), or in minimal medium containing a mixture of 3 mM 3-methylbenzoate and 0.2 % 
succinate as a co-carbon source that causes CCR of the PB1 promoter (white bars). Values are 
the average of three independent experiments +/- S. D. obtained for cells grown to the mid-
exponential phase. B, gel retardation analyses of PB1 probe as under Fig. 3B. Assays were 
performed using increasing concentrations (0 to 12 μM) of carbamoyl phosphate treated His6-
AccR (AccR-P). The free PB1 probe and the major PB1/AccR-P complex are indicated by 
arrows.  
 
FIGURE 9. AccR controls the activity of the PD promoter under anaerobic conditions. A 
and B, Azoarcus sp. CIB (CIB) and Azoarcus sp. CIBΔaccR (CIB∆accR) cells were grown 
aerobically (panel A) or anaerobically (panel B) in minimal medium containing 3 mM benzoate 
(black bars) or a mixture of 3 mM benzoate and 0.2% succinate (white bars) until mid-
exponential phase. Transcripts from the PD promoter were measured by real-time RT-PCR. 
Graphed values (in arbitrary units) are the average from three independent experiments +/- S. D. 
C, gel retardation analyses of PD probe as under Fig. 3B. Assays were performed at increasing 
concentrations (0 to 12 μM) of carbamoyl phosphate treated His6-AccR (AccR-P). The free PD 
probe and the major PD/AccR-P complex are indicated by arrows. D, sequence alignment of 
AccR binding regions in different catabolic promoters of Azoarcus sp. CIB. PN (OR2), operator 
region 2 of the PN promoter; PN (OR1), operator region 1 of the PN promoter; PD, PD promoter 
of the box cluster; PB1, PB1 promoter of the mbd cluster. A consensus sequence of the AccR 
operator is shown at the bottom. Nucleotides identical to the consensus are shown in bold.  
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TABLE 1  
Bacterial strains and plasmids used in this study 
 
Strain or plasmid Relevant genotype or phenotypea Ref. or source 
E. coli strains   
DH10B F ,´ mcrA Δ(mrr hsdRMS-mcrBC) φ80dlacΔM15 ΔlacX74 deoR recA1 araD139 Δ(ara-leu)7697 
galU galK rpsL (Smr) endA1 nupG 
 
Invitrogen 
M15 Strain for regulated high level expression with pQE vectors 
 
Qiagen 
MC4100 araD139 Δ(argF-lac)U169 rpsL150 (Smr) relA1 flbB5301 deoC1 ptsF25 rbsR 
 
28 
AFMCPN Kmr Rfr, MC4100 spontaneous rifampicin-resistant mutant harboring a chromosomal insertion 
of the PN::lacZ translational fusion 
23 
SM10 λpir Kmr thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu λpir lysogen 29 
S17-1λpir Tpr Smr recA thi hsdRM+ RP4::2-Tc::Mu::Km Tn7 λpir lysogen 30 
XLI-Bue MRA (P2) Δ(mcrA)183,  Δ(mcrCB-hsdSMR-mrr)173, endA1, gyrA96, supE44, relA1, thi-1, lac, P2 lysogen 
 
Stratagene 
Azoarcus sp.CIB strains   
CIB Wild type strain 20 
CIBΔaccR             Azoarcus sp. strain CIB with a deletion of the accR  gene This work 
Plasmids    
pQE32 Apr, oriColE1, T5 promoter lac operator, λ to/E. coli rrnB T1 terminators, N-terminal His6 
 
Qiagen 
pQE32-His6AccR Apr, pQE32 derivative for expression of His6-accR; carries a 636 bp BamHI to PstI fragment 
generated using primers 5’HisaccR and 3’HisaccR (Table 2) 
 
This work 
pQE32-His6CAccR Apr, pQE32 derivative for expression of His6-CaccR; carries  a 232-bp BamHI to PstI fragment 
generated using 5’HisCaccR and 3’HisaccR (Table 2) 
 
This work 
pQE32- His6AccRD60E Apr, pQE32 derivative for expression of His6- accRD60E; carries a 636 bp BamHI to PstI 
fragment generated using flanking primers 5’HisaccR and 3’HisaccR and overlapping PCR 
mutagenesis primers 5´AccRD60E and 3´AccRD60E. 
 
This work 
pREP4 Kmr, plasmid that expresses the lacI repressor 
 
Qiagen 
pECOR7 Apr, pUC19 harbouring a 7.1 kb EcoRI fragment containing the bzdRNO genes 20 
pKNG101 Smr, oriR6K, Mob+. Suicide vector with a sacB selection marker for gene replacement by 
double site homologous recombination 
 
31 
pKNG101∆accR Smr, pKNG101 derivative carrying the ∆accR allele as a 1.4 kb BamHI to SpeI fragment 
assembled using the four AccRmut primers listed in Table 2 
 
This work 
pIZ1016 Gmr, oripBBR1, Mob+, lacZα, Ptac/lacIq, broad-host-range cloning and expression vector 32 
pIZAccSR Gmr, pIZ1016 derivative expressing accR from the Ptac promoter; carries a 3.3 kb SalI to SpeI 
fragment amplified using primers 5’AccSR and 3’AccSR (Table 2) 
 
This work 
pIZAccRD60E Gmr, pIZ1016 derivative expressing the His6-accRD60E from the Ptac promoter; carries a 0.6 
kb BamHI to PstI fragment derived from pQE32- His6AccRD60E 
 
This work 
pBBR1MCS-5 Gmr, oripBBR1, Mob+, lacZα, Plac, broad-host-range cloning and expression vector 
 
33 
pBBR5AccR Gmr, pBBR1MCS-5 derivative expressing the accR gene from the Plac promoter; carries a 697 
bp BamHI to XbaI fragment generated using primers 5’AccRExt and 3’AccRExt (Table 2) 
 
This work 
pBBR5PN Gmr, pBBR1MCS-5 derivative harbouring a PN::lacZ translational fusion 23 
pBBR5PNI Gmr, pBBR1MCS-5 derivative harbouring a 4.2 kb BamHI to XbaI fragment that expresses the 
PNI::lacZ translational fusion. The truncated PNI promoter spans from position -61 to +79 with 
respect to the transcription start site  
This work 
pIZPB1 Gmr, pIZ1016 derivative harbouring a PB1::lacZ translational fusion 
 
34 
pJCD-PN                                          
 
Apr , pJCD01 derivative harbouring a 585-bp EcoRI fragment that includes the PN promoter 25 
 
aApr, ampicillin-resistant; Gmr, gentamicin-resistant; Kmr, kanamycin-resistant; Rfr, rifampicin-resistant; Smr, streptomycin-resistant.  
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TABLE 2 
Oligonucleotides used in this study 
 
* Introduced restriction sites are underlined with the corresponding enzyme given in brackets. 
 
 
 
 
 
 
 
 
 
 
 
Primers Sequence* Use 
5’HisaccR 5’-CGGGATCCTTACCGCACCGTCCGCCGTA (BamHI) Amplification of the 5’-end of accR; used to 
construct His-tagged accR and accRD60E genes 
3’HisaccR 5’-AACTGCAGTCAGCACGTTCTGCACGAGTTCG (PstI) Amplification of the 3’-end of accR gene; used 
to construct the accR, CaccR, and accRD60E 
genes 
5’6HisCAccR 5’-CGGGATCCTTCGGCAGCTCGAGGCGGAGA (BamHI) Amplification of the 5’-end of CaccR; used to 
construct His-tagged CaccR  
5’AccRD60E 
3’AccRD60E 
5’-CTCGTGCTCGAAGTGCGCATG 
5’-CATGCGCACTTCGAGCACGAG 
Internal accR primers used to introduce the 
accRD60E substitution  
5’AccSR 
 
3’AccSR 
5’-ACGCGTCGACTGACCTAAGGAGGTAAATAATGTCCGACT 
     CTGCCGAATCCG (SalI) 
5’-GGACTAGTTCAGCGGCCGCCACCTCC (SpeI) 
Used to amplify and clone the accSR genes into 
plasmid pIZAccSR 
5’AccRext 
3’AccRext 
5’-CGGGATCCTAGTTAACTAGGAAGGGGGTACCATCTTCTC (BamHI) 
5’-GCTCTAGACAGGCCGGCACATCCGTCAGCG (XbaI) 
Amplification of the accR gene into plasmid 
pBBR5AccR 
5’AccRmut(BamHI 
3’AccRmut (XbaI) 
5’-CGGGATCCGCGGAGGTCTCGCGCCAGC (BamHI) 
5’-GCTCTAGACATTGTTCAGGTACGGCGGACG (XbaI) 
Amplification of a 762 bp BamHI/XbaI 
fragment, spanning the upstream region of accR, 
for constructing the ∆accR allele in 
pKNG101∆accR  
5’AccRmut(XbaI) 
3’AccRmut (SpeI) 
5’-GCTCTAGAGGCGGCCGCTGACGGATG (XbaI) 
5’-CCACTAGTCCATTACGCTGAGGAACCTTGCG (SpeI) 
Amplification of the a 642 bp XbaI/SpeI 
fragment, spanning the downstream region of  
accR, for constructing the ∆accR allele in 
pKNG101∆accR  
5’pboxdQ 
3’pboxdQ 
5’-CAACTCCAGTGCCTGTGCG 
5’-GAGAGGAGACAATCAGGTGAAGC 
RT-PCR amplification of cDNA – a 153 bp 
product that reports PD promoter activity 
 
5’RTpN1 
3’RTpN2 
5’-GCAACACATCAGAGGAGATAG 
5’-GTGTAGGTACACATCGTTGC 
RT-PCR amplification of cDNA – a 141 bp 
product that reports PN promoter activity  
5´POLIIIHK 
3´POLIIIHK 
5’-CGAAACGTCGGATGCACGC 
5’-GCGCAGGCCTAGGAAGTCGAAC 
RT-PCR amplification of cDNA – a 166 bp 
product of dnaE used as internal control in RT-
PCR assays 
FPAdh 5’ 
FPAdh 3’ bis 
CGGAATTCGCACCTTCGATCCATTGCCC (EcoRI) 
AAAAGTACTCGGTTGCTGTGATGCTGTGTC (ScaI) 
Amplification of a 234 bp boxDR intergenic 
fragment – PD probe 
5IVTPN CGGAATTCCGTGCATCAATGATCCGGCAAG(EcoRI) 5’-end of PN promoter, used with 3IVTPN to 
amplify the 376 bp PN probe 
3IVTPN CGGAATTCCATCGAACTATCTCCTCTGATG(EcoRI) 3’-end of PN  promoter, used to amplify the PN, 
PN2, and PN2mut probes 
5’PN3 
3’PN3 
TTTCCGCTCGCGTTCGCTCTC 
AATCTTTCTTGCCGCAACGC 
Amplification of the 93 bp PN3 probe  
5’PN2 AATGCAATCAAGTGCATGCAAACG Used with 3IVTPN to amplify the 162 bp PN2 
probe 
5’PN mut3 AAACCCCTGATCAAGTGCATGCA Used with 3IVTPN to amplify the 165 bp PN2mut  
probe 
5’ScaI PB1 
3’EcoRI PB1 
AAAAGTACTGGTATTACGGTAAGTGCTCCA (ScaI) 
CCGGAATTCCCTGCGCGCGGCACTATG (EcoRI) 
Amplification of the 251 bp PB1 probe 
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PN(OR2)             TTGCA ATGCA ACAAAA TGCAT TTCATGC 
PN(OR1)             AAAAA ATGCA ATCAAG TGCAT GCAAACG 
PD                  CAAAA CTGCA  TCTT  TACAT GGCTTGC 
PB1                  TCGCC ATGCG  CCG   TCCAT GCTCTCA 
  Consensus                 ATGCA        TGCAT 
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